SEC Form D · Amendment · filed February 4, 2015
Mnemosyne Pharmaceuticals Inc
Offering
$13.0M
Sold
$12.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PROVIDENCE, RI
Type
—
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (12)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗